Log In
Print
BCIQ
Print
Print this Print this
 

INV-17

  Manage Alerts
Collapse Summary General Information
Company Innovimmune Biotherapeutics Inc.
DescriptionOral small molecule RAR-related orphan receptor C thymus-specific isoform (RORgamma2; RORgammaT) inverse agonist
Molecular Target RAR-related orphan receptor C thymus-specific isoform (RORgamma2) (RORgammaT)
Mechanism of Action 
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today